Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe

Contributed by: Business Wire

Logo

Business Wire logo

Images

vMap is a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute.
vMap is a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute.
Business Wire embedded0

Tags

Health
Medical Devices
Technology
Health Technology
Software
Artificial Intelligence
Cardiology
CE Mark for vMap

More Like This

PR Newswire associated0

EnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology Assets

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

PR Newswire associated0

Biosense Webster Announces CE Mark approval in Europe for VARIPULSE™ Pulsed Field Ablation (PFA) Platform

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System

PR Newswire associated0

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Imricor VISABL-VT Clinical Trial Enrollment

Imricor Commences VISABL-VT Trial

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

PR Newswire associated0

EnChannel Medical Raises $82.2M in Oversubscribed Series-B Financing to Advance Full-Chamber 5D Atrial Fibrillation Mapping and Personalized Pulsed-Field Ablation Therapy

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us